Top 5 Medical Device VC Deals, H1 2010

A simplified diabetes device, two eye treatments, a surgical back device, and diagnostic biomarkers--these five technologies attracted the most venture capital funding in the first half of 2010. At the halfway point, Intuity Medical and its all-in-one glucose monitoring system gained the most funding.

In the second quarter, the industry landed $755 million on 95 deals, up 40 percent from the first quarter, according to PriceWaterhouseCoopers. Overall in the first half, medical device makers drew in $1.272 billion in 156 device deals. Report >>

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.